Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06238986 · ClinicalTrials.gov registry record
Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 9
- Enrollment target
NCT06238986: Clinical Trial study, sponsored by Mayo Clinic.
NCT06238986 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06238986 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This study evaluates the relationship between alterations in the GI microbiome and GI inflammation on symptom burden in women with breast cancer receiving chemotherapy.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2024-03-22 |
| Est. Completion | 2024-11-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06238986
The ClinicalTrials.gov registry entry for NCT06238986 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06238986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06238986 about?
NCT06238986 is a clinical study titled "Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy". This study evaluates the relationship between alterations in the GI microbiome and GI inflammation on symptom burden in women with breast cancer receiving chemotherapy.
What is the current status of trial NCT06238986?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2024-03-22. Estimated completion is 2024-11-18.
What interventions are being tested in trial NCT06238986?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06238986?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.